THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Gilead and PAHO establish regional pathway for twice-yearly lenacapavir access
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Gilead and PAHO announced an agreement using PAHO’s Regional Revolving Funds to support country-led adoption and implementation of twice-yearly lenacapavir for HIV prevention across PAHO Member States in Latin America and the Caribbean.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- International, International
- Source checked
- September 28, 2026
FOLLOW THE STORY